Microba Life Sciences LimitedASX: MAP

Microba launches GI Navigator in Australia and the UK

· Issued by Microba Life Sciences Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/microba-launches-gi-navigator-in-australia-and-the-uk

Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call

Microba launches GI Navigator in Australia and the UK Microba Life Sciences Limited (ASX: MAP) (Microba or the Company) is pleased to announce the commercial launch of GI Navigator, a new clinical gut test designed to help healthcare practitioners resolve complex gastrointestinal (GI) symptoms,...

View Attachment

6ix hasn’t read this filing yet.

Microba Life Sciences Limited on 6ix

Earlier from Microba Life Sciences

Later from Microba Life Sciences

All Microba Life Sciences news releases